Pacira BioSciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCRX and other ETFs, options, and stocks.

About PCRX

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. 

CEO
Frank D. Lee
CEOFrank D. Lee
Employees
829
Employees829
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
2006
Founded2006
Employees
829
Employees829

PCRX Key Statistics

Market cap
1.02B
Market cap1.02B
Price-Earnings ratio
70.98
Price-Earnings ratio70.98
Dividend yield
—
Dividend yield—
Average volume
555.53K
Average volume555.53K
High today
$26.00
High today$26.00
Low today
$24.58
Low today$24.58
Open price
$24.58
Open price$24.58
Volume
705.65K
Volume705.65K
52 Week high
$27.66
52 Week high$27.66
52 Week low
$18.80
52 Week low$18.80

Stock Snapshot

As of today, Pacira BioSciences(PCRX) shares are valued at $25.56. The company's market cap stands at 1.02B, with a P/E ratio of 70.98.

On 2026-09-24, Pacira BioSciences(PCRX) stock moved within a range of $24.58 to $26.00. With shares now at $25.56, the stock is trading +4.0% above its intraday low and -1.7% below the session's peak.

Trading volume for Pacira BioSciences(PCRX) stock has reached 705.65K, versus its average volume of 555.53K.

The stock's 52-week range extends from a low of $18.80 to a high of $27.66.

The stock's 52-week range extends from a low of $18.80 to a high of $27.66.

PCRX News

Nasdaq 17h
Oppenheimer Initiates Coverage of Pacira BioSciences with Outperform

Fintel reports that on September 23, 2026, Oppenheimer initiated coverage of Pacira BioSciences (NASDAQGS:PCRX) (DB:82P) with a Outperform recommendation. Paci...

Oppenheimer Initiates Coverage of Pacira BioSciences with Outperform
Investing.com 2d
Oppenheimer initiates Pacira stock with outperform rating - Investing.com

...

Oppenheimer initiates Pacira stock with outperform rating - Investing.com

Analyst ratings

56%

of 9 ratings
Buy
55.6%
Hold
33.3%
Sell
11.1%

People also own

Based on the portfolios of people who own PCRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.